Wells Fargo
OGN icon

Wells Fargo’s Organon & Co OGN Stock Holding History

Wells Fargo’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,800
Closed -$478K – 7354
2021
Q2 		$478K Buy
+15,800
New +$520K ﹤0.01% 4643

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Wells Fargo's OGN Position: Q1 2026 in Review

Wells Fargo reduced its Organon & Co (OGN) stake by 23% in Q1 2026, selling an estimated $1.58M and leaving 700,599 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

Wells Fargo first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $53.3M in Q3 2021. 606 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Wells Fargo held 700,599 shares of Organon & Co worth $4.2M as of Q1 2026.
  • Wells Fargo sold 210,289 Organon & Co shares in Q1 2026, an estimated $1.58M.
  • Organon & Co made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2739 holding.
  • Wells Fargo first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Wells Fargo's Organon & Co position peaked at $53.3M in Q3 2021.
  • 606 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.